Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-02-01FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) filed by Chattem, Inc., indicating an approved update…
-
CLINICAL_TRIALS trial_result · 2008-01-16Clinical Trial Update: Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma [NA]
Terminated clinical trial evaluating an immunotoxin on activated human macrophages in individuals with allergic rhinitis or mild intermitten…
-
FDA approval · 2008-01-15FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved the original ANDA for cetirizine hydrochloride tablets from Dr. Reddy's Laboratories Limited, marking the approval of a generic…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis [Phase 4]
Phase 4 clinical trial of Levocetirizine 5 mg demonstrated reductions in allergic rhinitis symptoms, airway resistance, and sleep impairment…
-
FDA approval · 2008-01-10FDA Approved: ALVESCO — Original Application (Covis Pharma US, Inc)
The FDA approved ALVESCO (ciclesonide) nasal spray from Covis Pharma US, Inc. through an original NDA (NDA021658) for the treatment of aller…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-12-31FDA Approved: CAREONE ALLERGY RELIEF — Supplemental Application (American Sales Company)
FDA approved a supplemental application for CAREONE ALLERGY RELIEF (fexofenadine hydrochloride) under ANDA076447, filed by American Sales Co…
-
FDA approval · 2007-12-28FDA Approved: CETIRIZINE HCL — Original Application (GLENMARK THERAPEUTICS INC., USA)
FDA approved Glenmark's cetirizine HCl Original Application (ANDA), granting marketing rights for a generic cetirizine product. Indications …
-
FDA approval · 2007-12-27FDA Approved: ALL DAY ALLERGY RELIEF — Original Application (Dolgencorp, Inc. (DOLLAR GENERAL & REXALL))
FDA approved ALL DAY ALLERGY RELIEF (cetirizine hydrochloride) from Dolgencorp as an original application for an over-the-counter antihistam…
-
FDA approval · 2007-12-27FDA Approved: ALLERGY RELIEF — Original Application (Allegiant Health)
The FDA approved a generic cetirizine HCl 10 mg tablet under Allegiant Health (ANDA078317) for allergy relief.
-
FDA approval · 2007-12-27FDA Approved: BETR REMEDIES ALL DAY ALLERGY RELIEF — Original Application (Live Betr LLC)
FDA approved a new generic version of cetirizine hydrochloride under BETR REMEDIES ALL DAY ALLERGY RELIEF for over-the-counter allergy relie…
-
FDA approval · 2007-12-27FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Ohm Laboratories Inc.)
FDA approved cetirizine hydrochloride as a generic oral antihistamine under an original application for Ohm Laboratories Inc., for relief of…
-
FDA approval · 2007-12-27FDA Approved: CETIRIZINE HCL — Original Application (GERI-CARE PHARMACEUTICAL CORP)
FDA approved the original application for cetirizine hydrochloride 10 mg (cetirizine HCl) for use in treating allergic rhinitis and urticari…
-
FDA approval · 2007-12-27FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan Pharmaceuticals' original ANDA for cetirizine hydrochloride, a generic antihistamine used to treat allergic rhinitis and …
-
FDA approval · 2007-12-20FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
FDA approved a supplemental application for Claritin (loratadine) filed by Bayer HealthCare LLC.
-
FDA approval · 2007-11-21FDA Approved: OMNARIS — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Omnaris (ciclesonide) submitted by Covis Pharma US, Inc., authorizing an update to the produ…
-
FDA approval · 2007-11-16FDA Approved: CHILDRENS ZYRTEC — Original Application (Kenvue Brands LLC)
FDA approved an original application for Children's Zyrtec (cetirizine hydrochloride) developed by Kenvue Brands LLC.
-
FDA label_change · 2007-11-16FDA Approved: ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC (cetirizine hydrochloride) filed by Kenvue Brands LLC, resulting in changes to the produc…
-
FDA approval · 2007-11-09FDA Approved: ZYRTEC-D — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for ZYRTEC-D (cetirizine hydrochloride and pseudoephedrine hydrochloride) by Kenvue Brands LLC.
-
FDA approval · 2007-10-18FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) submitted by Chattem, Inc.
-
CLINICAL_TRIALS trial_result · 2007-09-21Clinical Trial Update: Safety of ALK Ragweed Tablet [Phase 1]
A Phase 1 safety update reporting early safety findings for the ALK Ragweed Tablet in individuals with ragweed allergy.
-
CLINICAL_TRIALS trial_result · 2007-09-20Clinical Trial Update: Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating the safety and efficacy of a grass pollen allergen vaccine. The study status is completed.
-
FDA approval · 2007-09-12FDA Approved: FLUTICASONE PROPIONATE — Original Application (Golden State Medical Supply, Inc.)
FDA approved the original application for Fluticasone Propionate, submitted by Golden State Medical Supply, Inc.
-
FDA approval · 2007-09-06FDA Approved: GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE — Supplemental Application (WALGREEN COMPANY)
FDA approved Walgreens' supplemental application for Guaifenesin and Pseudoephedrine Hydrochloride.
-
FDA approval · 2007-08-09FDA Approved: CARBZAH — Supplemental Application (IPG Pharmaceuticals, inc.)
FDA approved a supplemental application for CARBZAH (carbinoxamine maleate) from IPG Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2007-06-12Clinical Trial Update: Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide [NA]
A clinical trial investigating grass allergen immunotherapy and bronchial inflammation in asthma and allergic rhinitis. The status of the st…